Intra-Cellular Therapies
ITCI
Reported
Wednesday, October 30
Q3 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | -0.20 | -0.25 | -0.05 | -25.00% |
| Revenue | 172M | 175M | 3.03M | 1.76% |
WhatIF - Earnings
EPS Missed Expectations by -$0.05
Intra-Cellular Therapies (ITCI:NASDAQ) has never missed EPS by this much before
There’s a first time for everything